Head of Phase I unit
Department of Oncology, Rigshospitalet
Morten Mau-Sørensen holds a position as Head of Phase I unit, Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
He is president of the Danish Association for Cancer Research and a member of the Danish Health Medical Agengcy’s panel on experimental therapy.
Dr. Mau-Sørensen’s research focuses on early clinical development of cancer therapies including first-in-man trials, biomarkers, targeted therapies based on genomic profiling and circulating tumor DNA.
Dr Mau-Sørensen is member of the ESMO Faculty on Principles of Clinical Trials and Systemic Therapy